198 related articles for article (PubMed ID: 36437956)
1. HOXA-AS2 may be a potential prognostic biomarker in human cancers: A meta-analysis and bioinformatics analysis.
Zhang F; Zhang G; Zhang H; Pu X; Chi F; Zhang D; Xin X; Gao M; Luo W; Li X
Front Genet; 2022; 13():944278. PubMed ID: 36437956
[No Abstract] [Full Text] [Related]
2. LncRNA HOXA‑AS2 is a prognostic and clinicopathological predictor in patients with cancer: A meta‑analysis.
Xiao T; Yan A; Tan L; Zhu H; Gao W
Oncol Lett; 2024 May; 27(5):226. PubMed ID: 38586205
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the prognostic and clinicopathological significance of HOXA-AS2 in human cancers: a systematic review and meta-analysis.
Lu B; Liu Z; Ji X; Zhang X
Transl Cancer Res; 2023 Mar; 12(3):605-615. PubMed ID: 37033343
[TBL] [Abstract][Full Text] [Related]
4. HOXA-AS2 may predict the prognosis of solid tumors among Chinese patients: A meta-analysis and bioinformatic analysis.
Wang Q; Zhang W; Deng C; Lin S; Zhou Y
Front Oncol; 2022; 12():1030825. PubMed ID: 36387249
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Clinicopathological Value of Rac1 in Cancer Survival: Evidence from a Meta-Analysis.
Lou S; Wang P; Yang J; Ma J; Liu C; Zhou M
J Cancer; 2018; 9(14):2571-2579. PubMed ID: 30026856
[No Abstract] [Full Text] [Related]
6. Up-regulation of long non-coding RNA HOXA-AS2 in non-small cell lung cancer is associated with worse survival outcome.
Li Y; Jiang H
Int J Clin Exp Pathol; 2017; 10(9):9690-9696. PubMed ID: 31966850
[TBL] [Abstract][Full Text] [Related]
7. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of HOXA-AS2 LncRNA in Patients with Gastric Cancer and Its Association with Helicobacter pylori Infection.
Rajabi A; Riahi A; Shirabadi-Arani H; Moaddab Y; Haghi M; Safaralizadeh R
J Gastrointest Cancer; 2022 Mar; 53(1):72-77. PubMed ID: 33174119
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA TUG1 as a potential prognostic biomarker in human cancers: a meta-analysis.
Ma PJ; Guan QK; Meng L; Qin N; Zhao J; Jin BZ
Oncotarget; 2017 Sep; 8(37):62454-62462. PubMed ID: 28977959
[TBL] [Abstract][Full Text] [Related]
11. The Value of LncRNA BCAR4 as a Prognostic Biomarker on Clinical Outcomes in Human Cancers.
Tu C; Ren X; He J; Zhang C; Chen R; Wang W; Li Z
J Cancer; 2019; 10(24):5992-6002. PubMed ID: 31762809
[No Abstract] [Full Text] [Related]
12. LncRNA HOXA-AS2 Promotes Tumor Progression by Suppressing miR-567 Expression in Oral Squamous Cell Carcinoma.
Chen R; Wang X; Zhou S; Zeng Z
Cancer Manag Res; 2021; 13():5443-5455. PubMed ID: 34267554
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of HOXA-AS2 suppresses proliferation and induces apoptosis in colorectal cancer.
Tong G; Wu X; Cheng B; Li L; Li X; Li Z; Nong Q; Chen X; Liu Y; Wang S
Am J Transl Res; 2017; 9(10):4545-4552. PubMed ID: 29118916
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive investigation of the clinical significance of long non-coding RNA HOXA-AS2 in acute myeloid leukemia using genome-wide RNA sequencing dataset.
Huang R; Liao X; Wang X; Li Q
J Cancer; 2021; 12(7):2151-2164. PubMed ID: 33754013
[No Abstract] [Full Text] [Related]
18. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and clinicopathological significance of PD-L1 in patients with renal cell carcinoma: a meta-analysis based on 1863 individuals.
Wang Z; Peng S; Xie H; Guo L; Cai Q; Shang Z; Jiang N; Niu Y
Clin Exp Med; 2018 May; 18(2):165-175. PubMed ID: 29362922
[TBL] [Abstract][Full Text] [Related]
20. A pan-cancer analysis of the prognostic value of long non-coding RNA LINC00662 in human cancers.
Zhang G; Wu B; Fu L; Liu B; Han X; Wang J; Zhang Y; Yu M; Ma H; Ma S; Cai H
Front Genet; 2022; 13():1063119. PubMed ID: 36568401
[No Abstract] [Full Text] [Related]
[Next] [New Search]